![Zhe Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zhe Wang
Directeur/Bestuurslid bij Zensun (Shanghai) Sci & Tech Co., Ltd.
Actieve functies van Zhe Wang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Zensun (Shanghai) Sci & Tech Co., Ltd.
![]() Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | 19-05-2020 | - |
Corporate Officer/Principal | 01-03-2018 | - |
Loopbaan van Zhe Wang
Statistieken
Internationaal
China | 2 |
Operationeel
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Zensun (Shanghai) Sci & Tech Co., Ltd.
![]() Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Health Technology |